JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms.
BACKGROUND: The JAK2 V617F mutation in exon 14 is the most common mutation in chronic myeloproliferative neoplasms (MPNs); deletion of the entire exon 14 is rarely detected. In our previous study of >10,000 samples from patients with suspected MPNs tested for JAK2 mutations by reverse transcripti...
Main Authors: | Wanlong Ma, Hagop Kantarjian, Xi Zhang, Xiuqiang Wang, Zhong Zhang, Chen-Hsiung Yeh, Susan O'Brien, Francis Giles, Jean Marie Bruey, Maher Albitar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2921382?pdf=render |
Similar Items
-
The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms
by: Burak Bahar, et al.
Published: (2016-01-01) -
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
by: Tai-Sung Lee, et al.
Published: (2011-01-01) -
Thromboprophylaxis of Patients with JAK2-Positive Myeloproliferative Neoplasms
by: Kimpton, Miriam
Published: (2021) -
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms
by: Graeme Greenfield, et al.
Published: (2020-09-01) -
Mouse models of myeloproliferative neoplasms: JAK of all grades
by: Juan Li, et al.
Published: (2011-05-01)